Asia Pacific Autotransfusion Devices Market Outlook and Strategic Insights by 2028

Asia Pacific Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Products and Accessories), Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)

Report Date : May 2022
Report Code : TIPRE00009982

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 140

The autotransfusion devices market in Asia-Pacific is expected to grow from US$ 250.35 million in 2021 to US$ 349.09 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028.

Healthcare budget allocations help countries in strengthening the workforces and improving the productivity of this sector, thereby contributing to economic performance. Rapid economic developments in India, China and other countries in Asia have augmented the healthcare expenditure in these countries, which enables them to establish better medical service infrastructure. Developing countries are significantly focusing on expanding and improving their healthcare facilities and services by leveraging technological advancements. The developing nations are focusing on introducing advanced healthcare facilities and services to overcome critical health issues. For instance, the government of India, through its National Health Authority agency, has implemented Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). This scheme has facilitated free/affordable treatment for cancer patients in the country. As per the data published by the National Health Authority of India, about 470,133 cancer cases have been treated under AB-PMJAY. These government initiatives are likely to provide lucrative opportunities for market players to introduce advanced technologies in autotransfusion devices, which, in turn, would propel the growth of the autotransfusion devices market during the forecast years.

Asia-Pacific Autotransfusion Devices Market Revenue and Forecast to 2028 (US$ Million)

Inquire for Discount

Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Request discounts available for Start-Ups & Universities

Asia-Pacific Autotransfusion Devices Market Segmentation

The Asia-Pacific autotransfusion devices market is segmented on the basis of type, application, end user, and country. The market, by type, is bifurcated into products and accessories. In 2021, the accessories segment held a larger market share. The market for the products segment is further segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest market share. The Asia-Pacific autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest market share in 2021. Based on end user, the market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Based on country, the market is segmented into China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific. Japan contributed a substantial share in 2021.

BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the Asia-Pacific autotransfusion devices market.

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Type, Application, and End User and Country

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Australia, China, Japan, South Korea

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Autotransfusion Devices Market – By Type

1.3.2 APAC Autotransfusion Devices Market – By Application

1.3.3 APAC Autotransfusion Devices Market – By End User

1.3.4 APAC Autotransfusion Devices Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Autotransfusion Devices Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Autotransfusion Devices Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Increase in Chronic Diseases

5.1.2 Rise in Transplants

5.1.3 Difficulty in Obtaining Blood of Rare Groups

5.2 Market Restraints

5.2.1 Product Recalls

5.2.2 Risks Associated with Autotransfusion

5.3 Market Opportunities

5.3.1 Elevated Healthcare Expenditure in Emerging Economies

5.4 Future Trends

5.4.1 Technological Developments in Autotransfusion Devices

5.5 Impact Analysis

6. Autotransfusion Devices Market– APAC Analysis

6.1 APAC Autotransfusion Devices Market Revenue Forecast and Analysis

7. APAC Autotransfusion Devices Market Analysis – By Type

7.1 Overview

7.2 APAC Autotransfusion Devices Market Revenue Share, by Type (2021 and 2028)

7.3 Products

7.3.1 Overview

7.3.2 Products: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 Intraoperative Autotransfusion Systems

7.3.3.1 Overview

7.3.3.2 Intraoperative Autotransfusion Systems: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 Postoperative Autotransfusion Systems

7.3.4.1 Overview

7.3.4.2 Postoperative Autotransfusion Systems: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Dual-Mode Autotransfusion Systems

7.3.5.1 Overview

7.3.5.2 Dual-Mode Autotransfusion Systems: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Accessories

7.4.1 Overview

7.4.2 Accessories: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Autotransfusion Devices Market Analysis – By Application

8.1 Overview

8.2 APAC Autotransfusion Devices Market Revenue Share, by Application (2021 and 2028)

8.3 Cardiac Surgeries

8.3.1 Overview

8.3.2 Cardiac Surgeries: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Orthopedic Surgeries

8.4.1 Overview

8.4.2 Orthopaedic Surgeries: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Organ Transplantation

8.5.1 Overview

8.5.2 Organ Transplantation: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Trauma Surgery Procedures

8.6.1 Overview

8.6.2 Trauma Surgery Procedures: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Autotransfusion Devices Market Analysis – By End User

9.1 Overview

9.2 APAC Autotransfusion Devices Market Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Specialty Clinics

9.4.1 Overview

9.4.2 Specialty Clinics: APAC Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgery Centers

9.5.1 Overview

9.5.2 Ambulatory Surgery Centers: APAC Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)

10. APAC Autotransfusion Devices Market – Country Analysis

10.1 APAC: Autotransfusion Devices Market

10.1.1 Overview

10.1.2 APAC: Autotransfusion Devices Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

10.1.2.1.3 China: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

10.1.2.3.3 India: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

10.1.2.4 South Korea: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 South Korea: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 South Korea: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

10.1.2.4.2.1 South Korea: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

10.1.2.4.3 South Korea: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 South Korea: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

10.1.2.5 Australia: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 Australia: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 Australia: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

10.1.2.5.2.1 Australia: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

10.1.2.5.3 Australia: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 Australia: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

11. APAC Autotransfusion Devices Market–Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Medtronic

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Fresenius SE & Co. KGaA

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Teleflex Incorporated

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 BD

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Zimmer Biomet

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Braile Biomedica

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Haemonetics Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 SARSTEDT AG and Co. KG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 LivaNova PLC

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Redax S.p.A.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. China: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

Table 3. China: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

Table 4. China: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

Table 5. China: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

Table 6. Japan: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

Table 7. Japan: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

Table 8. Japan: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

Table 9. Japan: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

Table 10. India: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

Table 11. India: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

Table 12. India: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

Table 13. India: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

Table 14. South Korea: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

Table 15. South Korea: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

Table 16. South Korea: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

Table 17. South Korea: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

Table 18. Australia: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

Table 19. Australia: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

Table 20. Australia: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

Table 21. Australia: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

Table 22. Rest of APAC: Autotransfusion Devices Market, by Type, 2019–2028 (USD Million)

Table 23. Rest of APAC: Autotransfusion Devices Market, by Product, 2019–2028 (USD Million)

Table 24. Rest of APAC: Autotransfusion Devices Market, by Application, 2019–2028 (USD Million)

Table 25. Rest of APAC: Autotransfusion Devices Market, by End User, 2019–2028 (USD Million)

Table 26. Organic Developments in the APAC Autotransfusion Devices Market

Table 27. Inorganic Developments in the APAC Autotransfusion Devices Market

Table 28. Glossary of Terms, Autotransfusion Devices Market

LIST OF FIGURES

Figure 1. APAC Autotransfusion Devices Market Segmentation

Figure 2. APAC Autotransfusion Devices Market, By Country

Figure 3. APAC Autotransfusion Devices Market Overview

Figure 4. Accessories Segment Held Largest Share of Product Segment in APAC Autotransfusion Devices Market

Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period

Figure 7. APAC: PEST Analysis

Figure 8. Experts Opinion

Figure 9. APAC Autotransfusion Devices Market Impact Analysis of Driver and Restraints

Figure 10. APAC Autotransfusion Devices Market– Revenue Forecast and Analysis – 2020- 2028

Figure 11. APAC Autotransfusion Devices Market Revenue Share, by Type (2021 and 2028)

Figure 12. Products: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Intraoperative Autotransfusion Systems: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028(US$ Million)

Figure 14. Postoperative Autotransfusion Systems: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Dual-Mode Autotransfusion System: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028(US$ Million)

Figure 16. Accessories: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Autotransfusion Devices Market Revenue Share, by Application (2021 and 2028)

Figure 18. Cardiac Surgeries: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Orthopaedic Surgeries: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Organ Transplantation: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Trauma Surgery Procedures: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Others: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. APAC Autotransfusion Devices Market Share, by End User (2021 and 2028 )

Figure 24. Hospitals: APAC Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Specialty Clinics: APAC Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)

Figure 26. Ambulatory Surgery Centers: APAC Autotransfusion Devices Market- Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC: Autotransfusion Devices Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. APAC: Autotransfusion Devices Market, by Country, 2021 & 2028 (%)

Figure 29. China: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Japan: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. India: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. South Korea: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Australia: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of APAC: Autotransfusion Devices Market – Revenue and Forecast to 2028 (USD Million)

BD
Braile Biomedica
Fresenius SE & Co. KGaA
Haemonetics Corporation
LivaNova PLC
Medtronic
Redax S.p.A.
SARSTEDT AG and Co. KG
Teleflex Incorporated
Zimmer Biomet

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
Validates and strengthens in-house secondary research findings
Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

Industry participants: VPs, business development managers, market intelligence managers and national sales managers
Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.